Recurrent episodes of anaphylaxis in a patient with haemophilia B: a case report.

about

Recurrent episodes of anaphylaxis in a patient with haemophilia B: a case report.

Item

http://www.wikidata.org/entity/Q42367924

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Recurrent episodes of anaphylaxis in a patient with haemophilia B: a case report.

@en

Recurrent episodes of anaphylaxis in a patient with haemophilia B: a case report.

@nl

type

Item

label

Recurrent episodes of anaphylaxis in a patient with haemophilia B: a case report.

@en

Recurrent episodes of anaphylaxis in a patient with haemophilia B: a case report.

@nl

prefLabel

Recurrent episodes of anaphylaxis in a patient with haemophilia B: a case report.

@en

Recurrent episodes of anaphylaxis in a patient with haemophilia B: a case report.

@nl

P1476

Recurrent episodes of anaphylaxis in a patient with haemophilia B: a case report.

@en

P2093

Elisa Bonetti

http://www.w3.org/2001/XMLSchema#string

Giovanni Poli

http://www.w3.org/2001/XMLSchema#string

Margherita Mauro

http://www.w3.org/2001/XMLSchema#string

Rita Balter

http://www.w3.org/2001/XMLSchema#string

P2860

Hemophilia B: molecular pathogenesis and mutation analysis.

Anaphylaxis in patients with congenital bleeding disorders and inhibitors.

Desensitization and immune tolerance induction in children with severe factor IX deficiency; inhibitors and adverse reactions to replacement therapy: a case-report and literature review.

Factor IX: molecular structure, epitopes, and mutations associated with inhibitor formation.

Successful eradication of inhibitor in a patient with severe haemophilia B and anaphylaxis to factor IX concentrates: is there a role for Rituximab and desensitization therapy?

Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk.

Induction of immune tolerance and suppression of anaphylaxis in a child with haemophilia B by simple plasmapheresis and antigen exposure.

Rituximab and desensitization for a patient with severe factor IX deficiency, inhibitors, and history of anaphylaxis.

The use of rituximab as an adjuvant for immune tolerance therapy in a hemophilia B boy with inhibitor and anaphylaxis to factor IX concentrate.

Measurement of anti-factor IX IgG subclasses in haemophilia B patients who developed inhibitors with episodes of allergic reactions to factor IX concentrates.

P304

582-584

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.2450/2016.0297-15

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Simone Cesaro

P577

2016-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27177407

http://www.w3.org/2001/XMLSchema#string

P921

hemophilia

anaphylaxis

hemophilia B

P932

5111390

http://www.w3.org/2001/XMLSchema#string